Connect with us

Technology

Medical Writing Market Size Indicating $ 9.09 billion by 2031, Featuring Profiles of Cactus Communications, Certara, Covance, Freyr Solutions, InClin Inc

Published

on

The report from The Insight Partners lists several stakeholders—including pharmaceutical and biotech companies, CROs, regulatory authorities, healthcare providers, and academic institutions—along with valuable insights on navigating the evolving market landscape and unlocking new opportunities successfully.

NEW YORK, Dec. 13, 2024 /PRNewswire/ — According to a new comprehensive report from The Insight Partners, global medical writing market is expected to reach US$ 9.09 billion by 2031 from US$ 3.44 billion in 2021; it is anticipated to record a CAGR of 10.2% during the forecast period. Medical writing is the creation of scientific documents that communicate medical, clinical, and healthcare information clearly and accurately. It involves preparing documents for regulatory submissions, clinical trial protocols, scientific publications, medical device documentation, and educational materials.

The medical writing market is growing owing to the expansion of the pharmaceutical, biotechnology, and medical device industries, along with an increase in clinical trials and drug development. Moreover, the growing emphasis on personalized medicine, stricter regulatory requirements, and globalization of healthcare are expected to favor market growth in the coming years.

Market leaders and key company profiles          

Cactus CommunicationsCertaraCovanceFreyr SolutionsInClin IncParexel International CorporationQuanticateSIRO Clinpharm Private LimitedSynchrogenixTrilogy Writing and Consulting GmbH

Request a Customized Copy of the Medical Writing Market Report @ https://www.theinsightpartners.com/reports/medical-writing-market/

Overview of Report Findings

Expansion of Pharmaceutical and Biotech Industries: As pharmaceutical and biotechnology sectors continue to innovate and develop drugs, therapies, and technologies, the demand for high-quality and precise documentation has surged. The growth is largely attributed to the increasing regulatory requirements, clinical trials, and research outputs that require detailed and well-structured documents such as clinical study reports, regulatory submission documents, and scientific publications. With the rapid development of mRNA vaccines, pharmaceutical companies, such as Pfizer and Moderna, have faced increased needs for medical writing expertise to ensure compliance and accuracy in regulatory filings and publications. Additionally, the increasing number of biotechnology startups has created a greater demand for outsourcing medical writing services to handle complex scientific data effectively. Thus, the expansion of the pharmaceutical and biotechnology industries drives the market.Expansion of Clinical Trials: With the increasing number of global clinical trials, especially in emerging fields such as oncology, rare diseases, and personalized medicines, there is a higher demand for medical writers to prepare essential documents, such as trial protocols, clinical study reports, investigator brochures, and patient consent forms. Additionally, the rise of decentralized and virtual clinical trials increases the complexity of documentation, requiring medical writers to adapt to new formats and regulatory standards. The growing clinical trials presents opportunities for medical writers to support sponsors and contract research organizations in ensuring regulatory compliance, accuracy, and clarity in the documentation of clinical trial data. The expansion of clinical trials provides significant opportunities in the medical writing industry as the need for precise documentation of trial processes and outcomes becomes critical.Geographical Insights: In 2021, North America led the medical writing market with a substantial revenue share, followed by Europe and APAC, respectively. Further, Asia Pacific is expected to register the highest CAGR during the forecast period.

Report Attributes

Details

Market Size in 2021

US$ 3.44 Billion

Market Size by 2031

US$ 9.09 Billion

CAGR

10.2 %

Base Year

2023

Forecast Period

 2024-2031

Historical Data

 2021-2022

Key Regional Coverage

North America (US, Canada, Mexico), Europe – [UK, Germany, France, Russia, Italy, Rest of Europe]

Asia-Pacific – [China, India, Japan, Australia, Rest of Asia-Pacific]

South and Central America [Brazil, Argentina, Rest of South and Central America]

Middle East and Africa [South Africa, Saudi Arabia, UAE and Rest of Middle East and Africa]

 

Market Segmentation

Based on type, the medical writing market is segmented into clinical writing, regulatory writing, and scientific writing. The clinical writing segment held the largest share of the market in 2021.By application, the medical writing market is categorized into medical journalism, medical education, and medico marketing. The medical education segment accounted for the largest share of the market in 2021.In terms of end users, the medical writing market is bifurcated into pharmaceutical and biotechnology companies and contract research organizations (CROs). The pharmaceutical and biotechnology companies segment led the market in 2021.The medical writing market is segmented into five major regions: North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Segments Covered –

By Type

Clinical WritingRegulatory WritingScientific Writing

By Application

Medical JournalismMedical EducationMedico Marketing

By End User

Pharmaceutical and Biotechnology CompaniesContract Research Organizations

Access PDF Sample Medical Writing Market Report (Including Graphs, Charts & Figures) – https://www.theinsightpartners.com/sample/TIPRE00008502/

Competitive Strategy and Development

Trending Topics: Regulatory writing for gene therapies and mRNA Vaccines, decentralized and virtual clinical trials, patient-centric documentation, and artificial intelligence in medical writing, among others.

Global Headlines on Medical Writing Market 

PPD Completes Evidera Acquisition, Strengthens Leadership in Real-World ResearchCognizant and Yseop Announced a Plan to Partner to Scale Medical Writing through Generative AI

Regional Analysis –

The Asia Pacific medical writing market is expected to reach US$ 983.51million in 2027 from US$ 560.59million in 2019. The market is estimated to grow with a CAGR of 7.3% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as an increased number of market players and an immense government support in the healthcare sector.The North America medical writing market is expected to reach US$ 1,266.23million in 2027 from US$ 732.95million in 2019. The market is estimated to grow with a CAGR of 7.1% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as increased requirement of medical writers due to stringent regulatory framework and robust growth in clinical trials.The Europe medical writing market is expected to reach US$ 1,114.92million in 2027 from US$ 655.84million in 2019. The market is estimated to grow with a CAGR of 6.9% from 2020-2027. The growth of this market is estimated to grow owing to key driving factors such as an increased number of clinical trials and an immense growth in the medical device industry

Get Flat 30% Discount on purchase of Medical Writing Market Research Report with 10% extra customization: https://www.theinsightpartners.com/buy/TIPRE00008502/

Conclusion

The medical writing market is experiencing robust growth, driven by healthcare advancements, regulatory demands, and the expansion of clinical research. With the increasing complexity of drug development, personalized medicine, and cutting-edge therapies such as gene and cell-based treatments, the demand for highly skilled medical writers is surging. The global expansion of clinical trials, the rise of real-world evidence, and the growing focus on patient-centric documentation are further contributing to new trends in the market. Additionally, the integration of digital health technologies and artificial intelligence is reshaping the way medical writers operate, creating new opportunities for efficiency and innovation. Moreover, as the pharmaceutical and biotech industries continue to evolve, medical writing is anticipated to remain a crucial element in ensuring clarity, accuracy, and regulatory compliance in scientific communication, thereby fueling market expansion.

More Trending Latest Research Life Sciences Research Reports by The Insight Partners –

The biopharmaceuticals market is expected to grow from US$ 3,29,966.22 million in 2022 to US$ 7,00,873.94 million by 2028; it is expected to grow at a CAGR of 13.4% from 2022 to 2028

Pediatric Medical Devices market size is projected to reach US$ 54.87 billion by 2031 from US$ 32.48 billion in 2023. The market is expected to register a CAGR of 6.78% during 2023–2031

Biopharmaceutical Processing Equipment and Consumable Market Size and Forecasts 2021 – 2031

3D Printing Medical Devices Market Size and Growth 2031

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person:
Ankit Mathur
E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876
Website – https://www.theinsightpartners.com/
Follow Us: LinkedIn | Facebook | Twitter 

Logo: https://mma.prnewswire.com/media/2520492/The_Insight_Partners_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/medical-writing-market-size-indicating–9-09-billion-by-2031–featuring-profiles-of-cactus-communications-certara-covance-freyr-solutions-inclin-inc-302331443.html

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Mastech Digital to Announce Second Quarter 2026 Financial Results; Participate in Upcoming Investor Conference

Published

on

By

PITTSBURGH, July 24, 2026 /PRNewswire/ — Mastech Digital, Inc. (NYSE American: MHH) (“Mastech Digital”), a leading provider of Digital Transformation IT Services, today announced the date for the release of its financial results for the second quarter ended June 30, 2026, and its participation in an upcoming investor conference.

Second Quarter 2026 Earnings:

Mastech Digital will report its financial results for the second quarter 2026 before the market opens on Thursday, August 6, 2026. Management will host a live conference call and webcast at 9:00 a.m. Eastern Time on that day to discuss the Company’s financial performance and operating results.  The conference call will be hosted by Nirav Patel, President and CEO, and Kannan Sugantharaman, Chief Financial and Operations Officer.

Those wishing to participate via webcast should access the call through Mastech Digital’s Investor Relations website at https://investors.mastechdigital.com. Those wishing to participate via telephone may dial in at 1-800-715-9871 (USA) or 1-646-307-1963 (International) with the passcode 7506988. The replay will be available via webcast through Mastech Digital’s Investor Relations website.

Upcoming Investor Conference:

Mr. Sugantharaman will host a fireside chat at the Sidoti Micro-Cap Investor Conference on Wednesday, August 19, 2026, at 9:15 a.m. Eastern Time.

Mastech Digital management is scheduled to host virtual one-on-one and small group meetings with investors during the conference on August 19-20, 2026. Investors interested in arranging a meeting should contact their Sidoti representative or reach out to the Mastech Digital investor relations team at investors@mastechdigital.com.

About Mastech Digital, Inc.

Mastech Digital (NYSE American: MHH) is a leading provider of Digital Transformation IT Services. The Company offers Data Management, Analytics & AI Solutions, and IT Staffing Services with a digital-first approach. A minority-owned enterprise, Mastech Digital is headquartered in Pittsburgh, PA, with offices across the U.S., Canada, Europe, and India. Visit us at www.mastechdigital.com.

Investor Relations Contact:
investors@mastechdigital.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/mastech-digital-to-announce-second-quarter-2026-financial-results-participate-in-upcoming-investor-conference-302834421.html

SOURCE Mastech Digital, Inc.

Continue Reading

Technology

SOLAI Limited Announces Extraordinary General Meeting

Published

on

By

AKRON, Ohio, July 24, 2026 /PRNewswire/ — SOLAI Limited (NYSE: SLAI) (“SOLAI” or the “Company”) (previously known as “BIT Mining Limited”), a technology-driven personal AI and digital infrastructure provider, today announced that it will hold its extraordinary general meeting of shareholders at 428 South Seiberling Street, Akron, Ohio, US on August 14, 2026 at 10:00 a.m., New York time.

Holders of record of ordinary shares and preference shares of the Company at the close of business on July 20, 2026, New York time (the “Record Date”) are entitled to receive notice of, and to attend and vote at, the extraordinary general meeting or any adjournment thereof. Holders of the Company’s American Depositary Shares (“ADSs”) who wish to exercise their voting rights for the underlying ordinary shares must act through the depositary of the Company’s ADS program, Deutsche Bank Trust Company Americas.

The notice of the extraordinary general meeting, which sets forth the resolutions to be submitted to shareholder approval at the extraordinary general meeting is available on the Investor Relations section of the Company’s website at https://ir.solai.com

About SOLAI Limited

SOLAI Limited (previously known as “BIT Mining Limited”) (NYSE: SLAI) (previously traded under “BTCM”) is a technology-driven personal AI and digital infrastructure provider. Building upon its historical legacy in digital asset mining and blockchain network operations, the Company is leveraging extensive experience in large-scale hardware deployment, data center operations, and high-performance computing to build the foundational infrastructure for personal AI computing and digital asset ecosystems globally.

For more information:

SOLAI Limited
ir@solai.com
ir.solai.com
www.solai.com 

Christensen Advisory
Jason Ng
Tel: +852-2117-0861
Email: solai@christensencomms.com 

 

View original content:https://www.prnewswire.com/news-releases/solai-limited-announces-extraordinary-general-meeting-302834034.html

SOURCE SOLAI Limited

Continue Reading

Technology

/U P D A T E — TrendAI/

Published

on

By

This release has been updated to include new information provided by TrendAI. The complete, corrected release follows, with additional details at the end:

TrendAI™ Adopts Claude Opus 5 to Advance Vulnerability Prioritization and Virtual Patching

As a participant in Anthropic’s Cyber Verification Program, TrendAI applies frontier reasoning to convert vulnerability intelligence into faster protection across hybrid environments

DALLAS, July 24, 2026 /PRNewswire/ — TrendAI™, the enterprise AI security leader from Trend Micro Incorporated (TYO: 4704; TSE: 4704), today announced it is adopting Claude Opus 5, Anthropic’s latest and most capable Opus model, to help security teams convert vulnerability intelligence into immediate protection, from prioritization to virtual patching. The move builds on TrendAI’s collaboration with Anthropic on Claude Opus 4.8, extending the same defensive focus to a model that delivers step-change gains in advanced reasoning, agentic workflows, and long-horizon analysis. As AI makes finding vulnerabilities easier than ever, the harder problem becomes protecting organizations faster than software can be permanently patched, and that is where TrendAI is putting Opus 5 to work.

As a participant in Anthropic’s Cyber Verification Program, which credentials organizations for the defensive use of frontier AI models, TrendAI is positioned to apply Claude Opus 5 to defensive security as access becomes available. The model is Zero Data Retention compatible, supporting TrendAI’s governance and data-protection requirements as it scales AI across security operations.

The work extends to TrendAI Threat Research, where frontier AI models are combined with our proprietary frontier intelligence engine and human expertise to generate pre-disclosure intelligence. Those insights power TrendAI Vision One™, delivering stronger detection, deeper forensic insights, and proactive protection through virtual patching.

Rachel Jin, Chief Platform and Business Officer, Head of TrendAI™:
“With Claude Opus 5, TrendAI can move from vulnerability intelligence to action faster than ever, prioritizing what matters most by exploitability and business impact. Finding the vulnerability was always the hard part. Now the challenge is protecting organizations faster than software can be permanently patched, and frontier reasoning is what changes that equation, extending all the way to virtual patching that protects customers before a vendor fix ships. This is what it means to secure the AI age, fearlessly.”

These capabilities support TrendAI Vision One™ in helping security analysts, AppSec teams, and SOC teams prioritize exposure, map attack paths, and accelerate mitigation, including virtual patching, across hybrid environments, moving vulnerability management from a static scanning process into a faster, context-aware risk mitigation workflow.

About TrendAI™
TrendAI™, the global AI security leader and enterprise business unit of Trend Micro, empowers organizations with full AI visibility and consolidated security that inspires confidence, drives innovation, and eliminates risk. Trusted by the largest enterprises and governments across 185 countries, TrendAI™ secures the entire organization, from identities, to infrastructure, to data. Global Fortune 500 companies rely on TrendAI™ to cut risk and stop threats up to three months earlier, powered by world-leading threat and attack intelligence. Through deep ecosystem partnerships with market leaders like NVIDIA, Anthropic, AWS, Google, and Microsoft, TrendAI™ empowers your organization to securely drive forward at the speed of AI. AI Fearlessly. Learn more: trendaisecurity.com

About Anthropic
Anthropic is an AI safety and research company dedicated to building reliable, interpretable, and steerable AI systems. Its Claude family of models, including Claude Opus 5, enables advanced capabilities across a wide range of applications, including code understanding and security analysis.

Update: The latest version of this release includes additional statements from TrendAI related to the original announcement.

View original content to download multimedia:https://www.prnewswire.com/news-releases/trendai-adopts-claude-opus-5-to-advance-vulnerability-prioritization-assessment-and-virtual-patching-302834362.html

SOURCE TrendAI

Continue Reading

Trending